302 results
8-K
INFIQ
Infinity Pharmaceuticals, Inc.
11 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:09pm
Nasdaq Listing Rules. However, there can be no assurance that, if the Company receives a delisting notice and appeals the delisting determination
8-K
INFIQ
Infinity Pharmaceuticals, Inc.
30 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
on The Nasdaq Global Select Market pending such compliance. However, there can be no assurance that the Panel will grant the Company’s request
DEFM14A
INFIQ
Infinity Pharmaceuticals, Inc.
6 Jun 23
Proxy related to merger
4:31pm
be no assurance that the Merger will be completed, or if it is completed, that it will be completed within the anticipated time period … to that effect. No assurance can be given that the Merger will qualify as a “reorganization” within the meaning of Section 368(a) of the Code.
Neither
8-K
846pl1 80c
7 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
c18q8w34
30 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:13pm
8-K
ekolu5
24 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:42pm